BioSpace News Archive

The following roundup is a collection of stories dealing with the HIMSS 2019 conference and is appropriate for special sections and for general use.

Decipher Biosciences, a leader in the field of urologic cancer genomics, today announced a research collaboration with Dendreon Pharmaceuticals

CEO Geert Cauwenbergh to Retire and Remain on Board of Directors

In honor of Presidents Day, the de Beaumont Foundation has released a quiz to share interesting facts about U.S. presidents and how their policy, advocacy, and private lives have influenced Americans’ health.

Healthcare knowledge provider BMJ has partnered with Editage to offer language editing and translation services to medical researchers who seek to publish in healthcare science journals.

March of Dimes, the nonprofit organization leading the fight for the health of all moms and babies, today announced a partnership with the National Basketball Wives Association (NBWA), the official nonprofit charitable organization that represents its membership, the NBA, NBA G-League, ABA and Harlem Globetrotters to create national and global impact for families across the country.

Based on the growing recognition that behavior – and not just clinical factors – critically affect health, Nascate today announced the launched of an online platform that provides key information on people’s behavior outside the healthcare environment and how that behavior may affect health, utilization, and costs.

BioCorRx Inc. (BICX), based in Anaheim, CA, Leader in addiction treatment solutions and drug development implementation, today announced that Brady Granier, CEO/President and Lourdes Felix, CFO/COO, will present live at VirtualInvestorConferences.com on February 20th.

German diagnostics company sphingotec GmbH (Hennigsdorf) reports that key opinion leaders have confirmed clinical utility of bio-ADM® (biologically active adrenomedullin), the company’s proprietary marker for vascular leakage (endothelial dysfunction), in patients with congestion in heart failure and in patients with severe sepsis.

Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Loxo Oncology, Inc. (NASDAQ:LOXO).